PubRank

J M Grinyó

Author PubWeight™ 61.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients. Am J Transplant 2012 2.17
2 HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 2006 1.85
3 Optimizing cadaveric organ procurement: the catalan and Spanish experience. Am J Transplant 2003 1.58
4 Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006 1.50
5 Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000 1.48
6 Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. Clin Nephrol 2008 1.40
7 Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999 1.07
8 Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997 1.02
9 Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol 2012 1.01
10 Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Clin Pharmacol Ther 1999 0.99
11 Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation. Am J Transplant 2013 0.97
12 Hypoxia stimulus: An adaptive immune response during dendritic cell maturation. Kidney Int 2008 0.97
13 Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis. Am J Transplant 2007 0.94
14 Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. Am J Transplant 2009 0.94
15 Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant 2011 0.93
16 New immunosuppresor strategies in the treatment of murine lupus nephritis. Lupus 2007 0.93
17 Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Clin Transplant 1998 0.92
18 Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients. Am J Transplant 2013 0.92
19 Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001 0.90
20 Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity. Transplantation 2001 0.89
21 Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001 0.87
22 Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther 2005 0.86
23 Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 2015 0.86
24 Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 2005 0.86
25 Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Kidney Int 1999 0.85
26 In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection. Gene Ther 2011 0.85
27 Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation 1998 0.85
28 Determination of ganciclovir in human plasma by ultra performance liquid chromatography-UV detection. Clin Biochem 2012 0.83
29 Protective effect of UR-12670 on chronic nephropathy induced by warm ischaemia in ageing uninephrectomized rats. Nephrol Dial Transplant 2001 0.83
30 Interstitial nephritis in sarcoidosis: simultaneous multiorgan involvement. Am J Kidney Dis 1995 0.82
31 Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. Transplantation 2000 0.81
32 Calcineurin-inhibitor-sparing immunosuppressive protocols. Transplant Proc 2005 0.81
33 Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus. Antimicrob Agents Chemother 2009 0.81
34 Quantification of interstitial chronic renal damage by means of texture analysis. Kidney Int 1994 0.80
35 Preservation of kidneys from marginal donors with pulsatile perfusion machine. Transplant Proc 1999 0.80
36 Tubular epithelial cells transfected with hHGF counteracts monocyte chemotactic protein-1 up-regulation after hypoxia/reoxygenation insult. Transplant Proc 2009 0.80
37 Glomerular size in early protocol biopsies is associated with graft outcome. Am J Transplant 2005 0.80
38 Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 1996 0.80
39 Recipient body surface area as a predictor of posttransplant renal allograft evolution. Transplantation 1998 0.80
40 Prevention and management of late renal allograft dysfunction. J Nephrol 2001 0.79
41 Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant 1999 0.79
42 Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient. Am J Transplant 2013 0.79
43 Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics. Transpl Infect Dis 2009 0.79
44 Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia 2012 0.79
45 Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival. Transplant Proc 2005 0.79
46 Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia. Am J Physiol Renal Physiol 2000 0.79
47 Subclinical rejection impairs glomerular adaptation after renal transplantation. Kidney Int 2006 0.79
48 [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation]. Nefrologia 2002 0.78
49 Thrombotic thrombocytopenic purpura with severe large artery branch involvement. Nephrol Dial Transplant 2005 0.78
50 The use of azithromycin for cyclosporin-induced gingival overgrowth. Br J Dermatol 1998 0.78
51 Dendritic cells phenotype fitting under hypoxia or lipopolysaccharide; adenosine 5'-triphosphate-binding cassette transporters far beyond an efflux pump. Clin Exp Immunol 2013 0.78
52 Donor structural and functional parameters are independent predictors of renal function at 3 months. Transplant Proc 2007 0.77
53 The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol. Nephrol Dial Transplant 1999 0.77
54 Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation. Transplant Proc 2011 0.77
55 Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation. Transplant Proc 1999 0.77
56 Revisiting double kidney transplantation: two kidneys provide better graft survival than one. Transplant Proc 2011 0.77
57 A good alternative to reduce the kidney shortage: kidneys from nonheartbeating donors. Transplantation 1998 0.76
58 Glomerulonephritis associated with hepatitis C virus infection after renal transplantation. Nephrol Dial Transplant 2000 0.76
59 De novo use of everolimus with elimination or minimization of cyclosporine in renal transplant recipients. Transplant Proc 2011 0.76
60 Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression. Transplant Proc 2005 0.76
61 Role of cold ischemia in acute rejection: characterization of a humoral-like acute rejection in experimental renal transplantation. Transplant Proc 2005 0.76
62 Immunosuppression for dual kidney transplantation with marginal organs: the old is better yet. Am J Transplant 2007 0.76
63 Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin. Kidney Int Suppl 1998 0.76
64 New immunosuppressive agent: expectations and controversies. Transplantation 2003 0.75
65 Cost-effectiveness of OKT3 induction therapy in cadaveric kidney transplantation. Am J Kidney Dis 1996 0.75
66 Peripheral blood lymphoid subsets and long-term clinical course of kidney recipients: a longitudinal study. Cytometry 1998 0.75
67 Influence of hematopoietic microchimerism in organ tolerance after kidney or heart transplantation. Transplant Proc 2003 0.75
68 Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Clin Exp Immunol 1998 0.75
69 Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression. Transplant Proc 2002 0.75
70 [Renal involvement in benign monoclonal gammopathies: an underdiagnosed condition]. Nefrologia 2008 0.75
71 Chylous ascites: an unusual complication of percutaneous peritoneal catheter implantation. Perit Dial Int 2006 0.75
72 Double kidney transplant. Transplant Proc 1999 0.75
73 Predictive value of cyclosporine blood levels during the absorption phase to estimate the area under the curve in stable renal transplant patients. Transplant Proc 2002 0.75
74 Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone. Transplant Proc 1995 0.75
75 Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine. Transplant Proc 2009 0.75
76 Multivariate analysis of prognostic factors in renal transplantation. Transplant Proc 1995 0.75
77 TGF-beta(1) gene expression in protocol biopsies from patients with stable renal allograft function. Transplant Proc 2001 0.75
78 Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients. Kidney Int Suppl 1999 0.75
79 Automated classification of renal interstitium and tubules by local texture analysis and a neural network. Anal Quant Cytol Histol 1996 0.75
80 Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression. Transplant Proc 2002 0.75
81 Automatic evaluation of renal interstitial volume fraction. Transplant Proc 1995 0.75
82 Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients. Transplant Proc 2003 0.75
83 An unusual cause of post-biopsy oliguria in an allograft. Nephrol Dial Transplant 1999 0.75
84 The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. Transplant Proc 2002 0.75
85 Sterile leukocyturia is associated with interstitial fibrosis and tubular atrophy in kidney allograft protocol biopsies. Am J Transplant 2014 0.75
86 Prophylaxis of urinary tract infection in renal transplantation: comparison of three different protocols using ceftriaxone-cloxacillin, aztreonam-cloxacillin, or aztreonam-amoxycillin-clavulanic acid. Transplant Proc 1995 0.75
87 Evolution of the organ donor profile in Catalonia. Transplant Proc 1999 0.75
88 Cholesterol embolism associated with macroscopic renal infarction. Nephrol Dial Transplant 1999 0.75
89 Arterial intimal thickening in stable renal allografts during the first year of follow-up. Transplant Proc 2001 0.75
90 MAG3 renogram deconvolution in kidney transplantation: utility of the measurement of initial tracer uptake. J Nucl Med 1997 0.75
91 [Toward individualized immunosuppression]. Nefrologia 2001 0.75
92 Mycophenolate-update after it has come of age. Nephrol Dial Transplant 1999 0.75
93 Correction to: Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. Expert Rev Clin Immunol 2015 0.75
94 Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. Exp Nephrol 1999 0.75
95 Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome. Transplant Proc 2004 0.75
96 Total glomerular number in stable renal allografts. Transplant Proc 2002 0.75
97 Cadaver kidney transplantation in Catalonia: successful organization. Transplant Proc 1999 0.75
98 Sequential study of immune mechanisms involved in graft acceptance in kidney transplantation. Transplant Proc 1995 0.75
99 Renal function reserve in stable grafts and its relationship to renal morphologic parameters. Transplant Proc 1999 0.75